NovaBridge Biosciences (NBP) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 11 Buy.
The consensus price target is $9.00, representing an upside of 246.2% from the current price $2.60.
Analysts estimate Earnings Per Share (EPS) of $-1.27 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-4.46 vs est $-1.27 (missed -252.5%). Analyst accuracy: 28%.
NBP Stock — 12-Month Price Forecast
$9.00
▲ +246.15% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for NovaBridge Biosciences, the price target is $9.00.
The average price target represents a +246.15% change from the last price of $2.60.
NBP Analyst Ratings
Buy
Based on 11 analysts giving stock ratings to NovaBridge Biosciences in the past 3 months
EPS Estimates — NBP
28%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual –$4.46
vs Est –$1.27
▼ 71.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — NBP
Revenue Trend
Analysts expect stable revenue going forward.
